sodium-pertechnetate-tc-99m and Hepatitis

sodium-pertechnetate-tc-99m has been researched along with Hepatitis* in 3 studies

Other Studies

3 other study(ies) available for sodium-pertechnetate-tc-99m and Hepatitis

ArticleYear
Variable portal circulation from inferior mesenteric vein assessed by per-rectal radionuclide administration.
    Nuclear medicine communications, 1995, Volume: 16, Issue:2

    The intrahepatic distribution of radioactivity after the per-rectal administration of 201T-chloride and/or 99Tcm-pertechnetate was investigated in 177 studies in 149 patients with no liver disease or diffuse liver disease and compared with that of 99Tcm-stannous (99Tcm-Sn) colloid scintigrams. The patients were classified into two groups: distribution of intrahepatic radioactivity of 201Tl and/or 99Tcm-pertechnetate scintigrams similar to (homogeneous) or different from (heterogeneous) that of 99Tcm-Sn-colloid scintigrams. The heterogeneous group was divided into three subgroups: increased radioactivity of the right lobe (right dominant pattern), increased radioactivity of the left lobe (left dominant pattern) and uneven distribution of radioactivity in both lobes (uneven pattern). Of the 80 patients in whom the studies were performed in the supine position at rest, 14 (17.5%) showed a heterogeneous pattern (8 right dominant, 4 left dominant, 2 uneven) and 66 (82.5%) a homogeneous pattern. In the 97 patients allowed free body movement, 6 (6.2%) showed a heterogeneous (1 right dominant, 5 left dominant) and 91 (93.8%) a homogeneous pattern. A significant difference in the incidence of heterogeneous distribution between the resting and free body movement groups was found (P < 0.05). One patient with a left dominant pattern after free body movement with 201Tl showed a right dominant pattern at rest in the 99Tcm-pertechnetate study. It is concluded that a heterogeneous intrahepatic distribution of inferior mesenteric vein blood is sometimes observed and that the distribution of portal vein blood flow seems to be affected by the patient's positioning and free body movement.

    Topics: Administration, Rectal; Hepatitis; Humans; Liver Circulation; Liver Cirrhosis; Liver Diseases; Mesenteric Veins; Movement; Portal System; Portal Vein; Posture; Radionuclide Imaging; Sodium Pertechnetate Tc 99m; Technetium Compounds; Thallium; Tin Compounds

1995
Per-rectal portal scintigraphy with technetium-99m pertechnetate for the early diagnosis of cirrhosis in patients with chronic hepatitis.
    Journal of hepatology, 1992, Volume: 14, Issue:2-3

    We evaluated the role of per-rectal portal scintigraphy with 99m-technetium pertechnetate (99m-Tc test) for early diagnosis of cirrhosis. Forty patients with biochemical evidence of chronic liver disease were studied. Laparobiopsy documented chronic active hepatitis (CAH) without cirrhosis in 22 of the patients and CAH with cirrhosis (CAHc) in 18 patients. Clinical or laboratory findings could not differentiate between CAH and CAHc. Twelve healthy volunteers served as controls. The results, expressed as shunt index (SI), i.e., the ratio between heart radioactivity and the sum of heart and liver radioactivity in the first 30 s of observation, were: controls 5.66 +/- 1.66, CAH 15.27 +/- 2.83 and CAHc 24.88 +/- 3.95. A significant difference between the mean SI values in the three groups studied (F = 142.71, p less than 0.0001) was observed. At values less than 17, our test showed a predictivity of 100% for cirrhosis exclusion, while at values higher than 19 the predictive positive value for a diagnosis of cirrhosis was 100%. Invasive diagnostic procedures should be performed only in patients with SI values between 17-19.

    Topics: Adult; Female; Hepatitis; Hepatitis B; Hepatitis C; Humans; Liver Cirrhosis; Liver Function Tests; Male; Portal System; Radionuclide Imaging; Reference Values; Sodium Pertechnetate Tc 99m

1992
Portal circulation by technetium-99m pertechnetate per-rectal portal scintigraphy.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1988, Volume: 29, Issue:4

    Portal circulation in patients with chronic liver diseases was evaluated by [99mTc]pertechnetate per-rectal scintigraphy. Technetium-99m pertechnetate (10 mCi) was instilled into the upper rectum, and serial scintigrams were taken. Radioactivity curves for the liver and heart were then recorded sequentially. Through analysis of these curves, the per-rectal portal shunt index (Sl) was calculated for six healthy subjects and 228 patients, 59 with chronic hepatitis, seven with idiopathic portal hypertension, six with primary biliary cirrhosis, and 156 with cirrhosis. In the healthy subjects, the Sl was 1.9-5.2% (mean 4.1%). In hepatitis, the mean Sl was 7.1%, and in cirrhosis, 52.9%. The Sl was higher in cirrhotic patients with esophageal varices than in those without (p less than 0.001), and in cirrhotic patients with encephalopathy than in those without (p less than 0.01). For some patients with portal hypertension, portal collateral circulation could be depicted, and images of changes in the portal collateral circulation after vascular anastomosis were seen.

    Topics: Administration, Rectal; Adult; Chronic Disease; Collateral Circulation; Esophageal and Gastric Varices; Female; Heart; Hepatitis; Humans; Hypertension, Portal; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases; Methods; Middle Aged; Portal System; Radionuclide Imaging; Sodium Pertechnetate Tc 99m; Vena Cava, Inferior

1988